+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Immune Pharmaceuticals - logo

Immune Pharmaceuticals is a clinical stage biopharmaceutical company that develops novel targeted therapeutics in the immuno-inflammation and immuno-oncology areas. The company's lead product candidate is Bertilimumab, a human monoclonal antibody, which is in Phase II clinical trial for the treatment of ulcerative colitis, bullous pemphigoid, and Crohn's disease. Immune Pharmaceuticals, Inc. was founded in 2010 and is headquartered in New York, New York.

Atopic Dermatitis (Atopic Eczema) - Pipeline Review, H1 2020 - Product Thumbnail Image

Atopic Dermatitis (Atopic Eczema) - Pipeline Review, H1 2020

  • Drug Pipelines
  • February 2020
  • 639 Pages
From
Atopic Dermatitis - Pipeline Review, H2 2019 - Product Thumbnail Image

Atopic Dermatitis - Pipeline Review, H2 2019

  • Drug Pipelines
  • November 2019
  • 597 Pages
From
From
From
From
From
From
Psoriasis - Pipeline Review, H1 2020 - Product Thumbnail Image

Psoriasis - Pipeline Review, H1 2020

  • Drug Pipelines
  • March 2020
  • 935 Pages
From
From
Diabetic Neuropathic Pain - Pipeline Insight, 2020 - Product Thumbnail Image

Diabetic Neuropathic Pain - Pipeline Insight, 2020

  • Drug Pipelines
  • February 2020
  • 106 Pages
From
Bullous Pemphigoid Global Clinical Trials Review, H2, 2018 - Product Thumbnail Image

Bullous Pemphigoid Global Clinical Trials Review, H2, 2018

  • Clinical Trials
  • December 2018
  • 59 Pages
From
US Transdermal Patch Market & Clinical Trial Insight - Product Thumbnail Image

US Transdermal Patch Market & Clinical Trial Insight

  • Clinical Trials
  • November 2015
  • 300 Pages
From
From
From
Loading Indicator
adroll